Jason Kane

The Levasseurs took out a second mortgage on their home and drained their savings, desperate to keep their older daughter in treatment.

Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the multimillion dollar, medically-intensive therapies.

Medicaid paperwork issues caused by the unwinding process have left families scrambling for months to get coverage for their young children with chronic conditions.

Patient advocates say states should never have kicked the developmentally disabled off Medicaid in the first place. 

The Supreme Court unanimously rejected an effort to roll back access to the most commonly-used abortion pill in the country, mifepristone. NBC News legal analyst Danny Cevallos provides analysis for TODAY.